Cell entry-associated conformational changes in reovirus particles are controlled by host protease activity

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 3466-3473

  Madren, Jillann A ^a   Sarkar, Payel ^a   Danthi, Pranav ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CHYMOTRYPSIN; MICRO1C PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; ENZYME ACTIVITY; ENZYME REGULATION; IN VITRO STUDY; INFECTIOUS SUBVIRION PARTICLE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REOVIRUS; VIRAL GENETICS; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS MORPHOLOGY; VIRUS PARTICLE;

ANIMALS; CAPSID PROTEINS; CELL LINE; CHYMOTRYPSIN; CRICETINAE; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE; ORTHOREOVIRUS, MAMMALIAN; PROTEIN CONFORMATION; REOVIRIDAE INFECTIONS; VIRION; VIRUS INTERNALIZATION;

MIRIDAE; ORTHOREOVIRUS;

EID: 84861306230     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06659-11     Document Type: Article

References (54)

1. Agosto MA, Ivanovic T, Nibert ML. 2006. Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc. Natl. Acad. Sci. U. S. A. 103: 16496-16501.
2. Agosto MA, Myers KS, Ivanovic T, Nibert ML. 2008. A positivefeedback mechanism promotes reovirus particle conversion to the intermediate associated with membrane penetration. Proc. Natl. Acad. Sci. U. S. A. 105: 10571-10576.
3. Amerongen HM, Wilson GAR, Fields BN, Neutra MR. 1994. Proteolytic processing of reovirus is required for adherence to intestinal M cells. J. Virol. 68: 8428-8432.
4. Bass DM, et al. 1990. Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice. J. Virol. 64: 1830-1833.
5. Bodkin DK, Fields BN. 1989. Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes. J. Virol. 63: 1188-1193.
6. Bodkin DK, Nibert ML, Fields BN. 1989. Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J. Virol. 63: 4676-4681.
7. Boehme KW, Ikizler M, Kobayashi T, Dermody TS. 2011. Reverse genetics for mammalian reovirus. Methods 55: 109-113.
8. Borsa J, Copps TP, Sargent MD, Long DG, Chapman JD. 1973. New intermediate subviral particles in the in vitro uncoating of reovirus virions by chymotrypsin. J. Virol. 11: 552-564.
9. Borsa J, Long DG, Copps TP, Sargent MD, Chapman JD. 1974. Reovirus transcriptase activation in vitro: further studies on the facilitation phenomenon. Intervirology 3: 15-35.
10. Borsa J, Long DG, Sargent MD, Copps TP, Chapman JD. 1974. Reovirus transcriptase activation in vitro: involvement of an endogenous uncoating activity in the second stage of the process. Intervirology 4: 171-188.
11. Borsa J, Sargent MD, Copps TP, Long DG, Chapman JD. 1973. Specific monovalent cation effects on modification of reovirus infectivity by chymotrypsin digestion in vitro. J. Virol. 11: 1017-1019.
12. Borsa J, Sargent MD, Ewing DD, Einspenner M. 1982. Perturbation of the switch-on of transcriptase activity in intermediate subviral particles from reovirus. J. Cell. Physiol. 112: 10-18.
13. Borsa J, Sargent MD, Lievaart PA, Copps TP. 1981. Reovirus: evidence for a second step in the intracellular uncoating and transcriptase activation process. Virology 111: 191-200.
14. Borsa J, Sargent MD, Long DG, Chapman JD. 1973. Extraordinary effects of specific monovalent cations on activation of reovirus transcriptase by chymotrypsin in vitro. J. Virol. 11: 207-217.
15. Chandran K, Farsetta DL, Nibert ML. 2002. Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein μ1 mediates membrane disruption. J. Virol. 76: 9920-9933.
16. Chandran K, Parker JS, Ehrlich M, Kirchhausen T, Nibert ML. 2003. The delta region of outer-capsid protein μ1 undergoes conformational change and release from reovirus particles during cell entry. J. Virol. 77: 13361-13375.
17. Chandran K, et al. 1999. In vitro recoating of reovirus cores with baculovirus-expressed outer-capsid proteinsμ1 andσ3. J. Virol. 73: 3941-3950.
18. Chang CT, Zweerink HJ. 1971. Fate of parental reovirus in infected cell. Virology 46: 544-555.
19. Danthi P, Coffey CM, Parker JS, Abel TW, Dermody TS. 2008. Independent regulation of reovirus membrane penetration and apoptosis by the mu1 phi domain. PLoS Pathog. 4: e1000248.
20. Danthi P, et al. 2010. From touchdown to transcription: the reovirus cell entry pathway. Curr. Top. Microbiol. Immunol. 343: 91-119.
21. Danthi P, et al. 2008. Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J. Virol. 82: 161-172.
22. Drayna D, Fields BN. 1982. Activation and characterization of the reovirus transcriptase: genetic analysis. J. Virol. 41: 110-118.
23. Ebert DH, Deussing J, Peters C, Dermody TS. 2002. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J. Biol. Chem. 277: 24609-24617.
24. Furlong DB, Nibert ML, Fields BN. 1988. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J. Virol. 62: 246-256.
25. Golden JW, Bahe JA, Lucas WT, Nibert ML, Schiff LA. 2004. Cathepsin S supports acid-independent infection by some reoviruses. J. Biol. Chem. 279: 8547-8557.
26. Golden JW, Schiff LA. 2005. Neutrophil elastase, an acid-independent serine protease, facilitates reovirus uncoating and infection in U937 promonocyte cells. Virol. J. 2: 48.
27. Harrison SC. 2008. Viral membrane fusion. Nat. Struct. Mol. Biol. 15: 690-698.
28. Ivanovic T, et al. 2008. Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J. 27: 1289-1298.
29. Jané-Valbuena J, Breun LA, Schiff LA, Nibert ML. 2002. Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein _3. J. Virol. 76: 5184-5197.
30. Johnson EM, et al. 2009. Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis. J. Virol. 83: 9630-9640.
31. Joklik WK. 1972. Studies on the effect of chymotrypsin on reovirions. Virology 49: 700-715.
32. Kobayashi T, et al. 2007. A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe 1: 147-157.
33. Kobayashi T, Ooms LS, Ikizler M, Chappell JD, Dermody TS. 2010. An improved reverse genetics system for mammalian orthoreoviruses. Virology 398: 194-200.
34. Liemann S, Chandran K, Baker TS, Nibert ML, Harrison SC. 2002. Structure of the reovirus membrane-penetration protein, μ1, in a complex with its protector protein, σ3. Cell 108: 283-295.
35. Luongo CL, et al. 1997. Localization of a C-terminal region of λ2 protein in reovirus cores. J. Virol. 71: 8035-8040.
36. Mendez II, Hermann LL, Hazelton PR, Coombs KM. 2000. A comparative analysis of freon substitutes in the purification of reovirus and calicivirus. J. Virol. Methods 90: 59-67.
37. Nibert ML, Chappell JD, Dermody TS. 1995. Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved μ1 protein. J. Virol. 69: 5057-5067.
38. Nibert ML, Fields BN. 1992. A carboxy-terminal fragment of protein μ1/μ1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J. Virol. 66: 6408-6418.
39. Nibert ML, Odegard AL, Agosto MA, Chandran K, Schiff LA. 2005. Putative autocleavage of reovirus μ1 protein in concert with outer-capsid disassembly and activation for membrane permeabilization. J. Mol. Biol. 345: 461-474.
40. Nibert ML, Schiff LA, Fields BN. 1991. Mammalian reoviruses contain a myristoylated structural protein. J. Virol. 65: 1960-1967.
41. Nygaard RM, Golden JW, Schiff LA. 2012. Impact of host proteases on reovirus infection in the respiratory tract. J. Virol. 86: 1238-1243.
42. Roy DM, Schneeman BO. 1981. Effect of soy protein, casein and trypsin inhibitor on cholesterol, bile acids and pancreatic enzymes in mice. J. Nutr. 111: 878-885.
43. Rubin DH, Fields BN. 1980. Molecular basis of reovirus virulence: role of the M2 gene. J. Exp. Med. 152: 853-868.
44. Sarkar P, Danthi P. 2010. Determinants of strain-specific differences in efficiency of reovirus entry. J. Virol. 84: 12723-12732.
45. Schiff LA, Nibert ML, Tyler KL. 2007. Orthoreoviruses and their replication, p 1853-1915. In Knipe DM, et al (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
46. Silverstein SC, Astell C, Levin DH, Schonberg M, Acs G. 1972. The mechanism of reovirus uncoating and gene activation in vivo. Virology 47: 797-806.
47. Smith RE, Zweerink HJ, Joklik WK. 1969. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39: 791-810.
48. Sturzenbecker LJ, Nibert ML, Furlong DB, Fields BN. 1987. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J. Virol. 61: 2351-2361.
49. Wetzel JD, et al. 1997. Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J. Virol. 71: 1362-1369.
50. White JM, Delos SE, Brecher M, Schornberg K. 2008. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43: 189-219.
51. Wilkins MR, et al. 1999. Protein identification and analysis tools in the ExPASy server. Methods Mol. Biol. 112: 531-552.
52. Zhang L, et al. 2009. Requirements for the formation of membrane pores by the reovirus myristoylated μ1N peptide. J. Virol. 83: 7004-7014.
53. Zhang L, Chandran K, Nibert ML, Harrison SC. 2006. Reovirus μ1 structural rearrangements that mediate membrane penetration. J. Virol. 80: 12367-12376.
54. Zhang X, et al. 2005. Features of reovirus outer capsid proteinμ1 revealed by electron cryomicroscopy and image reconstruction of the virion at 7.0 Å resolution. Structure 13: 1545-1557.